×

About
Team
Portfolio
News
Contact
LP Login

Skip to content

MENUMENU

About
Team
Portfolio
News
Contact
LP Login

Ikano Therapeutics, Inc.

Ikano developed Midazolam Nasal Spray (USL261) for acute repetitive seizures.

LinkedIn
561-200-3300
info@tullisfunds.com

Limited Partner Login

© 2023 Tullis Health Investors of Florida LLC | All Rights Reserved

Sitemap

The information on this site is intended for the management of growth companies interested in partnering with Tullis Health Investors. It is not appropriate for any current or prospective investors in a Tullis fund and should not be considered an actual or implied endorsement of any advice, analysis, report or other service rendered by Tullis Health Investors.